title: [Treatment protocol for sudden deafness].
abstract: There are two types of rapidly progressive sensorineural hearing loss: sudden hearing loss, which is generally unilateral and develops in less than 72 hours, and rapidly progressive sensorineural hearing loss, which develops over days or months. The origin of sudden deafness is difficult to establish. Several etiopathogenic factors have been postulated, such as viral infection, autoimmune origin, vascular and metabolic disease, rupture of the labyrinthine membrane, and, recently, immune-mediated inner ear disease. We made a retrospective study of 40 patients seen in our department. Patients were given a combined treatment with steroids, nimodipine, heparin, and oxygen. Patients were divided into two groups by intravenous or oral treatment.
authors.affiliation: Servicio de ORL, Clínica Puerta de Hierro, Universidad Autónoma de Madrid.
authors.forename: B
authors.initials: B
authors.lastname: Arellano
authors.forename: J R
authors.initials: JR
authors.lastname: García Berrocal
authors.forename: C
authors.initials: C
authors.lastname: Górriz
authors.forename: F M
authors.initials: FM
authors.lastname: González
authors.forename: J
authors.initials: J
authors.lastname: Vicente
authors.forename: R
authors.initials: R
authors.lastname: Ramírez Camacho
mesh_terms: D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001301:Audiometry, Pure-Tone; D002648:Child; D002985:Clinical Protocols; D006319:Hearing Loss, Sensorineural / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D009553:Nimodipine / Q000627:therapeutic use*; D012189:Retrospective Studies; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D014665:Vasodilator Agents; D009553:Nimodipine; D008775:Methylprednisolone
vernacular_title: Protocolo de tratamiento de la sordera súbita.